{"id":"https://openalex.org/W4415444792","doi":"https://doi.org/10.1158/1535-7163.targ-25-b078","title":"Abstract B078: NPX125, a novel ADC targeting B7-H7, shows potent activity in solid tumors","display_name":"Abstract B078: NPX125, a novel ADC targeting B7-H7, shows potent activity in solid tumors","publication_year":2025,"publication_date":"2025-10-22","ids":{"openalex":"https://openalex.org/W4415444792","doi":"https://doi.org/10.1158/1535-7163.targ-25-b078"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-25-b078","doi":"https://doi.org/10.1158/1535-7163.targ-25-b078","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-25-b078","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040275793","display_name":"Emilien J. Loeuillard","orcid":"https://orcid.org/0000-0002-3650-8100","observed_orcids":["https://orcid.org/0000-0002-3650-8100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilien Loeuillard","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001963621","display_name":"Bijan A. Etemad-Gilbertson","orcid":"https://orcid.org/0000-0002-7318-8441","observed_orcids":["https://orcid.org/0000-0002-7318-8441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bijan Etemad-Gilbertson","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076595615","display_name":"Susannah L. Hewitt","orcid":"https://orcid.org/0000-0003-2295-8634","observed_orcids":["https://orcid.org/0000-0003-2295-8634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susannah L. Hewitt","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059373950","display_name":"Yasmin Hashambhoy-Ramsay","orcid":"https://orcid.org/0000-0001-5762-666X","observed_orcids":["https://orcid.org/0000-0001-5762-666X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasmin Hashambhoy-Ramsay","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046520457","display_name":"Katalin Kis\u2010T\u00f3th","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katalin Kis-Toth","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045043147","display_name":"Jamie Strand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jamie Strand","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039953759","display_name":"Riale Gilligan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riale Gilligan","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004480578","display_name":"Silvia Ferrati","orcid":"https://orcid.org/0000-0001-7970-3996","observed_orcids":["https://orcid.org/0000-0001-7970-3996"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Ferrati","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019685125","display_name":"Tatiana I. Novobrantseva","orcid":"https://orcid.org/0000-0001-8070-403X","observed_orcids":["https://orcid.org/0000-0001-8070-403X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatiana Novobrantseva","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010778898","display_name":"Matthew P Rausch","orcid":"https://orcid.org/0000-0002-1573-5814","observed_orcids":["https://orcid.org/0000-0002-1573-5814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Rausch","raw_affiliation_strings":["1NextPoint Therapeutic, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NextPoint Therapeutic, Cambridge, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"10_Supplement","first_page":"B078","last_page":"B078"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.12790000438690186,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.04580000042915344,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9139999747276306},{"id":"https://openalex.org/keywords/b7-family","display_name":"B7 family","score":0.5979999899864197},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.843999981880188},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.4580000042915344},{"id":"https://openalex.org/keywords/antibody-internalization","display_name":"antibody internalization","score":0.6240000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7889999747276306},{"id":"https://openalex.org/keywords/xenograft-tumor-model","display_name":"xenograft tumor model","score":0.753000020980835},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.6949999928474426},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8410000205039978},{"id":"https://openalex.org/keywords/kidney-cancer","display_name":"kidney cancer","score":0.953000009059906},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-developability","display_name":"drug developability","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6951000094413757},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6373000144958496},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6144999861717224},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5763000249862671},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5735999941825867},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5504000186920166},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.531000018119812},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.4997999966144562},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49880000948905945},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4975000023841858},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.4970000088214874},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.44780001044273376},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4327000081539154},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4036000072956085},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4002000093460083},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.38989999890327454},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.38370001316070557},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37049999833106995},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36559998989105225},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.352400004863739},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.31779998540878296},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.2825999855995178},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2709999978542328},{"id":"https://openalex.org/C2777092746","wikidata":"https://www.wikidata.org/wiki/Q5939625","display_name":"Humanized antibody","level":4,"score":0.2685000002384186},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.2667999863624573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26420000195503235},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.26330000162124634},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.2632000148296356}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-25-b078","doi":"https://doi.org/10.1158/1535-7163.targ-25-b078","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-25-b078","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"B7-H7":[2,18,45,69,105,138,227,275,283,315,356,369,377],"is":[3,19,35],"a":[4,46,271,291,311,335,341,368,392,420],"member":[5],"of":[6,98,112,177,185,223,232,274,294,314,329,367,376,389,434],"the":[7,95,101,167,179,182,186,219,233,435],"B7":[8],"family,":[9],"known":[10],"for":[11,85],"its":[12,33,191],"role":[13],"as":[14,100,244,357,391],"an":[15,358],"immune":[16],"regulator.":[17],"upregulated":[20],"across":[21,114,373],"many":[22],"tumors":[23,113,201,430],"with":[24,37,71,145,161,225,270,321],"restricted":[25,229],"and":[26,32,76,88,92,120,136,181,215,235,278,297,362,442],"limited":[27],"expression":[28,107,228,276,378],"in":[29,86,89,110,166,173,202,250,266,288,304,306,331,334,428],"normal":[30,118,226],"tissues,":[31,119],"upregulation":[34],"correlated":[36],"poor":[38],"patient":[39],"outcomes.":[40],"Since":[41],"these":[42,352],"features":[43,170],"make":[44],"very":[47],"attractive":[48,359],"tumor":[49,121,267,308,337,348,380],"targeting":[50,370,423],"molecule,":[51],"NextPoint":[52],"has":[53],"developed":[54],"B7-H7-directed":[55],"antibody":[56],"drug":[57,81],"conjugate":[58],"(ADC).":[59],"ADCs":[60],"were":[61,83,171],"produced":[62],"using":[63,148],"antibodies":[64],"previously":[65],"raised":[66],"against":[67,198],"distinct":[68],"epitopes":[70],"cross-reactivity":[72],"to":[73,163,190,230,260],"both":[74,178],"human":[75],"cynomolgus":[77],"macaque":[78],"proteins.":[79],"These":[80],"molecules":[82],"tested":[84,197,303],"vitro":[87,152],"vivo":[90,194,307,332],"activity":[91,195,265,320,366,427],"developability,":[93],"enabling":[94],"lead":[96],"selection":[97],"NPX125":[99,237,262,301,330,390],"development":[102,388],"candidate.":[103],"Methods:":[104],"protein":[106,221,316],"was":[108,129,143,154,196,302,345],"assessed":[109,172],"hundreds":[111],"multiple":[115],"indications,":[116],"selected":[117],"cell":[122,140,158,211,253,268,285],"lines":[123,269],"by":[124,131,156,175],"immunohistochemistry":[125],"(IHC).":[126],"Binding":[127],"efficacy":[128],"measured":[130],"flow":[132],"cytometry":[133],"on":[134,282,379,439],"endogenous":[135],"overexpressing":[137],"positive":[139,252],"lines.":[141,286],"Internalization":[142],"tracked":[144],"Fabfluor-pH":[146],"reporter":[147],"Incucyte\u00ae":[149,247],"imaging.":[150],"In":[151,193],"cytotoxicity":[153],"evaluated":[155],"luminescence-based":[157],"viability":[159],"assays":[160],"CellTiter-Glo\u00ae":[162],"detect":[164],"ATP":[165],"media.":[168],"Pharmacokinetic":[169],"rats":[174,289],"measurement":[176],"IgG1":[180,188],"full":[183],"form":[184],"ADC,":[187,371],"conjugated":[189],"payload.":[192],"B7-H7\u2013expressing":[199],"xenograft":[200],"immunodeficient":[203],"mice.":[204],"Results:":[205],"Tumor":[206],"cells":[207],"from":[208],"colorectal,":[209],"non-small":[210],"lung,":[212],"pancreatic,":[213],"renal":[214],"gastric":[216],"cancer":[217],"displayed":[218],"highest":[220],"levels":[222,277,375],"B7-H7,":[224,424],"substructures":[231],"intestine":[234],"lung.":[236],"ADC":[238,360,422],"had":[239],"similar":[240],"on-cell":[241],"binding":[242],"capacities":[243],"parental":[245],"antibodies.":[246],"imaging":[248],"analyses":[249],"HER2":[251],"line":[254],"SKBR3":[255],"showed":[256,290],"faster":[257],"internalization":[258],"compared":[259],"Trastuzumab-Dxd.":[261],"demonstrated":[263],"cytotoxic":[264],"wide":[272,312],"range":[273,313],"significant":[279,364],"bystander":[280],"effect":[281],"negative":[284],"Pharmacokinetics":[287],"terminal":[292],"half-life":[293],">7":[295],"days":[296],"good":[298],"payload":[299],"stability.":[300],"several":[305],"models":[309],"expressing":[310],"levels,":[317],"demonstrating":[318],"anti-tumor":[319,365],"minimal":[322],"body":[323],"weight":[324],"changes.":[325],"A":[326],"single":[327,343],"dose":[328,344],"resulted":[333],"20-day":[336],"growth":[338],"delay,":[339],"while":[340],"lower":[342],"significantly":[346],"reducing":[347],"growth.":[349],"Conclusions:":[350],"Collectively,":[351],"preclinical":[353],"studies":[354],"establish":[355],"target":[361],"demonstrate":[363],"NPX125,":[372,419],"different":[374],"cells.":[381],"The":[382],"data":[383],"presented":[384],"here":[385],"supports":[386],"clinical":[387],"promising":[393],"treatment":[394],"strategy.":[395],"Citation":[396],"Format:":[397],"Emilien":[398],"Loeuillard,":[399],"Bijan":[400],"Etemad-Gilbertson,":[401],"Susannah":[402],"L.":[403],"Hewitt,":[404],"Yasmin":[405],"Hashambhoy-Ramsay,":[406],"Katalin":[407],"Kis-Toth,":[408],"Jamie":[409],"Strand,":[410],"Riale":[411],"Gilligan,":[412],"Silvia":[413],"Ferrati,":[414],"Tatiana":[415],"Novobrantseva,":[416],"Matthew":[417],"Rausch.":[418],"novel":[421],"shows":[425],"potent":[426],"solid":[429],"[abstract].":[431],"In:":[432],"Proceedings":[433],"AACR-NCI-EORTC":[436],"International":[437],"Conference":[438],"Molecular":[440],"Targets":[441],"Cancer":[443,454],"Therapeutics;":[444],"2025":[445],"Oct":[446],"22-26;":[447],"Boston,":[448],"MA.":[449],"Philadelphia":[450],"(PA):":[451],"AACR;":[452],"Mol":[453],"Ther":[455],"2025;24(10":[456],"Suppl):Abstract":[457],"nr":[458],"B078.":[459]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2025-10-23T00:00:00"}